PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0011860|type 2 diabetes mellitus |
| Sentences | 53 |
| PubMedID- 24278703 | Finally, the results of the accord trial showed that the combination of fenofibrate and simvastatin does not reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus, as compared with statin monotherapy [78]; only subgroups of patients with dyslipidemia seem to benefit from fibrate therapy. |
| PubMedID- 20047560 | Dyslipidaemia contributes to endothelial dysfunction and cvd (cardiovascular disease) in type 2 diabetes mellitus. |
| PubMedID- 26083376 | Pioglitazone has shown to have beneficial effect on cardiovascular diseases in patients with type 2 diabetes mellitus [18–20]. |
| PubMedID- 20228404 | Background: we investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease. |
| PubMedID- 25214836 | Left ventricular hypertrophy (lvh) and albuminuria are both markers for cardiovascular diseases (cvds) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25554536 | Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease. |
| PubMedID- 20040043 | [37] to suggest that rosiglitazone may contribute to a decrease in the development of vascular diseases associated with type 2 diabetes mellitus through actions on pecam-1. |
| PubMedID- 21390057 | Pulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24602748 | [primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: is it time to change our strategy. |
| PubMedID- 26246173 | Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association. |
| PubMedID- 24579534 | Pattern of dyslipidemia and evaluation of non-hdl cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus. |
| PubMedID- 19232762 | Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled clinical trials. |
| PubMedID- 24855344 | Several large-scale, prospective, randomized trials have documented that lowering glycemic levels can prevent the development of microvascular disease in people with type 2 diabetes mellitus (t2dm). |
| PubMedID- 23466074 | Role of relationship between hba1c, fibrinogen and hdl-cholesterol on cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 24076532 | (presence of macrovascular disease in type 2 diabetes mellitus; nct00298844). |
| PubMedID- 22338075 | Associations between exponential childhood growth superimposed on low birth weight and adult onset cardiovascular disease with glucose intolerance/type 2 diabetes mellitus exist in epidemiological investigations. |
| PubMedID- 20934769 | Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 20580779 | Our results suggested that incorporation of almonds into a healthy diet has beneficial effects on adiposity, glycemic control, and the lipid profile, thereby potentially decreasing the risk for cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 26395643 | Coenzyme q10 and oxidative stress, the association with peripheral sensory neuropathy and cardiovascular disease in type 2 diabetes mellitus. |
| PubMedID- 22440125 | Microalbuminuria is one of the strongest predictors of both adverse renal and cardiovascular disease (cvd) outcomes in patients with type 2 diabetes mellitus. |
| PubMedID- 21955281 | Background: type 2 diabetes mellitus increases the risk of atherosclerotic cardiovascular disease. |
| PubMedID- 22285702 | We investigated the effect of rhr on the incidence of type 2 diabetes mellitus (t2dm) in patients with clinically manifest vascular diseases. |
| PubMedID- 20550659 | The action to control cardiovascular risk in diabetes (accord) study investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease [1]. |
| PubMedID- 24918803 | Interventions targeted at modifiable risk factors, such as smoking cessation and management of hypertension and dyslipidemia, reduce the risk of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24920930 | Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. |
| PubMedID- 21398276 | Circulating angiopoietic cells and diabetic retinopathy in type 2 diabetes mellitus, with or without macrovascular disease. |
| PubMedID- 19875998 | The impact of obesity on cardiovascular disease (cvd) outcomes in patients with type 2 diabetes mellitus (t2dm) and established coronary artery disease (cad) is controversial; whether bmi and/or waist circumference correlate with atherothrombotic risk factors in such patients is uncertain. |
| PubMedID- 25212259 | Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the basque country prospective complications and mortality study risk engine (bascore). |
| PubMedID- 25815676 | Glucagon-like peptide-1 (glp-1) has been demonstrated to play an important role in type 2 diabetes mellitus, leading to cardiovascular diseases. |
| PubMedID- 25708055 | This study aimed to assess the effects of active and passive smoking exposure on the development of cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 20847892 | Evidence suggests that the maintenance of a large muscle mass may reduce metabolic risk factors—namely, obesity, dyslipidaemia, and type 2 diabetes mellitus—associated with cardiovascular disease [13–15]. |
| PubMedID- 26089896 | The results of this study indicated unfavorable upward trends in serum lipid levels and in the prevalence of dyslipidemia, chd, and cerebrovascular disease among patients with newly diagnosed type 2 diabetes mellitus in the southwest chinese han population. |
| PubMedID- 21625418 | The goal for non-hdl cholesterol has been reported to be the level of ldl cholesterol plus 30 mg/dl.36 in type 2 diabetics, several characteristics such as elevated triglycerides, decreased hdl cholesterol, and elevated small dense ldl, are well-known.25 because non-hdl cholesterol reflects all apolipoprotein b-containing atherogenic lipoproteins, non-hdl cholesterol may be useful in predicting cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 19859073 | The burden of microvascular disease in patients with type 2 diabetes mellitus continues to escalate worldwide. |
| PubMedID- 26246459 | Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association. |
| PubMedID- 26116592 | Plasma adiponectin levels inversely correlate to clinical parameters in type 2 diabetes mellitus patients with macrovascular diseases. |
| PubMedID- 23466101 | Objectives: low levels of blood adiponectin contribute to an increased risk of cardiovascular disease (cvd) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22430605 | In view of the high incidence of macrovascular diseases in patients with type 2 diabetes mellitus and microalbuminuria, the study evaluates the association of microalbuminuria with fasting plasma apo b48 levels, a marker of the residual presence of intestinally derived trls lipoproteins, thought to be highly atherogenic. |
| PubMedID- 26244041 | A recent review identified twelve risk equations for the prediction of cardiovascular disease in subjects with type 2 diabetes mellitus (t2dm) [6]. |
| PubMedID- 21963020 | Preliminary evidence in support of fruit intake for the prevention of cardiovascular disease in patients with type 2 diabetes mellitus (t2dm) is still limited. |
| PubMedID- 25238222 | What is it about very low density lipoproteins (vldl) and cardiovascular disease in patients with type 2 diabetes mellitus: is it the triglycerides or the cholesterol. |
| PubMedID- 23227510 | [a current model for predicting the risk of cardiovascular diseases in patients with type 2 diabetes mellitus]. |
| PubMedID- 25251664 | Patient empowerment programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study. |
| PubMedID- 21933841 | Purpose: to evaluate myocardial microvascular disease in patients with type 2 diabetes mellitus (dm) using myocardial contrast echocardiography (mce) and to report on its diagnostic accuracy using single photon emission tomography (spect) as reference test. |
| PubMedID- 25923078 | type 2 diabetes mellitus patients with cardiovascular disease showed higher expression of plasma retinol binding protein and glutathione peroxidase-3 compared to those without cardiovascular disease and non-diabetic controls. |
| PubMedID- 25256018 | Aims: this study aimed to investigate the impact of early-onset diabetes on the risk of microvascular diseases in chinese with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24567354 | Increased white blood cell (wbc) count is related to cardiovascular disease in patients with type 2 diabetes mellitus; raised neutrophil lymphocyte ratio (nlr) is associated with metabolic syndrome. |
| PubMedID- 25527522 | Conclusions: in our series, type 2 diabetes mellitus patients with cardiovascular disease at baseline present with an increased risk of developing diabetic peripheral neuropathy at 10 years of follow-up. |
| PubMedID- 26130877 | Winners in each category were as follows: best fellow poster, "diet pattern and cardiovascular disease among women with type 2 diabetes mellitus," by hyun joon shin, md; best resident poster, "oral squamous cell carcinoma: current concepts in imaging, staging, and fibular osteocutaneous free-flap reconstruction," by r. |
| PubMedID- 24465050 | And, would monotherapy with either or both of those drugs reduce the risk of cardiovascular disease events in patients with type 2 diabetes mellitus? |
Page: 1 2